Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tau Networks in Psychotic Alzheimer's Disease
Sponsor: Northwell Health
Summary
This research project aims to understand the brain mechanisms behind the manifestation of psychotic symptoms in Alzheimer´s disease (AD), and nature of the unique relationship with tau pathology. Amongst the cognitive manifestations of psychosis are impairments related to frontal circuits (social cognition, working memory and executive function deficits). The investigator's previous work suggests a role of tau pathology (one of the hallmarks of AD neuropathology) in the manifestation of psychosis in AD. However, the cerebral mechanisms that underly this association remain poorly understood. The overarching aim of the study is is to investigate the mechanisms by which tau network pathology may promote the presentation of psychosis in AD.
Key Details
Gender
All
Age Range
65 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
91
Start Date
2023-04-13
Completion Date
2029-12-31
Last Updated
2026-04-08
Healthy Volunteers
Yes
Interventions
[18F]-PI2620 PET scan
The PET scan will measure the regional distribution of tau aggregation in AD patients with and without psychosis compared to Cognitively Unimpaired Healthy participants with the PET radiotracer \[18F\]-PI2620.
Locations (1)
The Feinstein Institutes for Medical Research
Manhasset, New York, United States